Literature DB >> 28236250

Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015.

Kousaku Matsubara1, Kiyoshi Hoshina2, Masatoshi Kondo3, Isao Miyairi4, Yoshiya Yukitake5, Yusuke Ito6, Kisei Minami7, Ryuichi Genkawa8.   

Abstract

PURPOSE: This study aimed to describe the epidemiology of childhood group B streptococcus (GBS) disease including late late-onset disease (LLOD) and to clinically characterize recurrent cases and twin-sibling cases in Japan.
METHODS: We collected information on infants (<1 year of age) with invasive GBS disease and institutional information about births and transfers through a nationwide questionnaire between 2011 and 2015.
RESULTS: We identified 133 infants with early-onset disease (EOD), 274 late-onset disease (LOD), and 38 LLOD from 149 institutes. The case fatality rate (CFR) of EOD, LOD, and LLOD was 4.5, 4.4, and 0%, respectively. CFR in EOD was significantly (P < 0.001) associated with preterm birth, but not that in LOD and LLOD. Twenty-nine percent of infants with meningitis (49/169) had neurologic sequelae. We showed clinical details of 12 recurrent cases that accounted for 2.8% of the total patients, and 4 sets of both twins affected; 4 of 12 recurrent cases and 3 of 4 twin-sibling sets were also associated with preterm birth. Based on the livebirth number of 581,488, the instituted-based incidence of EOD, LOD, and LLOD was estimated as 0.09 (95% CI 0.06-0.11), 0.12 (95% CI 0.11-0.14), and 0.01 (95% CI 0.01-0.02) per 1000 livebirths, respectively.
CONCLUSIONS: CFR of EOD and LOD in Japan is comparable with that in high-income European countries or the United States, and their incidence is much lower. Our findings also describe the clinical details of LLOD, recurrent infections, and infections in twin siblings. This study is the largest among Asian childhood GBS studies ever reported.

Entities:  

Keywords:  Epidemiology; Group B Streptococcus; Japan; Recurrence; Streptococcus agalactiae; Twin

Mesh:

Year:  2017        PMID: 28236250     DOI: 10.1007/s15010-017-0995-2

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

1.  Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany.

Authors:  Kirsten Fluegge; Sven Supper; Anette Siedler; Reinhard Berner
Journal:  Clin Infect Dis       Date:  2005-02-02       Impact factor: 9.079

2.  Group B streptococcus sepsis in twins.

Authors:  Harbir Singh Arora; Saurabh Shankar Chiwane; Nahed Abdel-Haq; Kevin Valentine; Paul Lephart; Basim Isa Asmar
Journal:  Pediatr Infect Dis J       Date:  2015-05       Impact factor: 2.129

3.  Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition.

Authors:  Hisanori Minakami; Tsugio Maeda; Tomoyuki Fujii; Hiromi Hamada; Yoshinori Iitsuka; Atsuo Itakura; Hiroaki Itoh; Mitsutoshi Iwashita; Takeshi Kanagawa; Makoto Kanai; Yoshio Kasuga; Masakiyo Kawabata; Kosuke Kobayashi; Tomomi Kotani; Yoshiki Kudo; Yasuo Makino; Shigeki Matsubara; Hideo Matsuda; Kiyonori Miura; Takeshi Murakoshi; Jun Murotsuki; Akihide Ohkuchi; Yasumasa Ohno; Yoko Ohshiba; Shoji Satoh; Akihiko Sekizawa; Mayumi Sugiura; Shunji Suzuki; Tsuneo Takahashi; Yuki Tsukahara; Nobuya Unno; Hiroyuki Yoshikawa
Journal:  J Obstet Gynaecol Res       Date:  2014-06       Impact factor: 1.730

4.  A 5-year review of recurrent group B streptococcal disease: lessons from twin infants.

Authors:  E H Moylett; M Fernandez; M A Rench; M E Hickman; C J Baker
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

5.  Recurrent group B streptococcal disease in infants: Who should receive rifampin?

Authors:  J T Atkins; G P Heresi; T M Coque; C J Baker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

Review 6.  Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects.

Authors:  P A Green; K V Singh; B E Murray; C J Baker
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

7.  Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial.

Authors:  Gilbert G G Donders; Scott A Halperin; Roland Devlieger; Sherryl Baker; Pietro Forte; Frederick Wittke; Karen S Slobod; Peter M Dull
Journal:  Obstet Gynecol       Date:  2016-02       Impact factor: 7.661

8.  Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004-2010.

Authors:  Kousaku Matsubara; Kiyoshi Hoshina; Yoko Suzuki
Journal:  Int J Infect Dis       Date:  2013-01-08       Impact factor: 3.623

9.  Synchronous recurrence of group B streptococcal late-onset sepsis in twins.

Authors:  Roland Elling; Markus Hufnagel; Aruni de Zoysa; Fabian Lander; Katharina Zumstein; Marcus Krueger; Philipp Henneke
Journal:  Pediatrics       Date:  2014-04-07       Impact factor: 7.124

10.  Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections.

Authors:  M Morozumi; T Wajima; Y Kuwata; N Chiba; K Sunaoshi; K Sugita; H Sakata; S Iwata; K Ubukata
Journal:  Epidemiol Infect       Date:  2013-07-18       Impact factor: 4.434

View more
  8 in total

1.  Difficulties in establishing the source of infection in recurrent neonatal group B streptococcal disease.

Authors:  A Méndez-Echevarría; E Ferreira; T Del Rosal; M P Romero; F Baquero-Artigao
Journal:  Infection       Date:  2017-09-13       Impact factor: 3.553

Review 2.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

3.  Clinical and Microbiological Characteristics of Group B Streptococcus from Pregnant Women and Diseased Infants in Intrapartum Antibiotic Prophylaxis Era in Taiwan.

Authors:  Chien-Chung Lee; Jen-Fu Hsu; Rajendra Prasad Janapatla; Chyi-Liang Chen; Ying-Li Zhou; Reyin Lien; Cheng-Hsun Chiu
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

4.  National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational study.

Authors:  Yoshiki Kusama; Kenta Ito; Haruhisa Fukuda; Nobuaki Matsunaga; Norio Ohmagari
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

5.  Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis.

Authors:  Mirjam Freudenhammer; Konstantinos Karampatsas; Kirsty Le Doare; Fabian Lander; Jakob Armann; Daniel Acero Moreno; Margaret Boyle; Horst Buxmann; Ruth Campbell; Victoria Chalker; Robert Cunney; Lorraine Doherty; Eleri Davies; Androulla Efstratiou; Roland Elling; Matthias Endmann; Jochen Essers; Roland Hentschel; Christine E Jones; Steffen Kallsen; Georgia Kapatai; Marcus Krüger; Shamez Ladhani; Theresa Lamagni; Diane Lindsay; Mary Meehan; Catherine P O'Sullivan; Darshana Patel; Arlene J Reynolds; Claudia Roll; Sven Schulzke; Andrew Smith; Anja Stein; Axel von der Wense; Egbert Voss; Christian Wieg; Christoph Härtel; Paul T Heath; Philipp Henneke
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

6.  Management of group b streptococcus-positive pregnant women at maternity homes in JAPAN: a questionnaire survey of compliance among midwives.

Authors:  Kotomi Yamaguchi; Kazutomo Ohashi
Journal:  Matern Health Neonatol Perinatol       Date:  2018-02-05

7.  Late onset group B streptococcus disease manifesting as acute suppurative parotitis.

Authors:  Nagisa Ujita; Yu Kawasaki; Kousaku Matsubara; Kaya Kim; Akiyoshi Naito; Masayuki Hori; Kenichi Isome; Aya Iwata; Yoshimichi Yamaguchi; Bin Chang
Journal:  IDCases       Date:  2020-05-11

8.  Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-Analyses.

Authors:  Konstantinos Karampatsas; Hannah Davies; Maren Mynarek; Nick Andrews; Paul T Heath; Kirsty Le Doare
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.